SREBF1 and obesity disorder: Mendelson et al. proposed that the methylation level of SREBF1 intron 1 in the adrenal gland (tissue other than blood) would be involved in the development of obesity and that methylation changes in blood represent a biomarker of trans-tissue differential methylation [7].